期刊文献+

48例原发性胆汁性肝硬化的临床资料分析 被引量:6

Clinical characteristics of primary biliary cirrhosis : A report of 48 cases
下载PDF
导出
摘要 目的 分析原发性胆汁性肝硬化 (primarybiliarycirrhosis ,PBC)患者的临床特征 ,以指导对该病的诊断和治疗。方法 对 48例PBC患者的一般资料、病程、临床表现、血清化学指标、免疫学及病理学改变等进行回顾性分析。结果 本组患者中女性 44例 ,女 :男比例为 11:1,确诊时年龄 2 6~ 82岁 ( 5 4.2 3± 12 .5岁 ) ,初诊至确诊的时间平均为 46.69月 ( 10天~ 2 64月 )。伴有迁延性丙氨酸氨基转移酶、天门冬氨酸氨基转移酶异常、高胆红素血症、高碱性磷酸酶、γ 谷氨酰基转移酶血症、高球蛋白血症 ,存在自身抗体 ,93 .7%的患者抗线粒体抗体和 /或抗线粒体M2亚型抗体阳性。结论 PBC在女性多见 ,肝脏损伤严重 ,确诊时基本至晚期 。 ObjectiveTo study the clinical features of primary biliary cirrhosis (PBC) in order to facilitate recognition of the disease. MethodsGeneral status, clinical manifestations and laboratory findings of 48 patients with PBC were reviewed. ResultsAmong the 48 patients ,44 were females with a female/male ratio of 11:1 and the age range was 26~82 years old (mean 54.23±12.5岁). The mean time interval between the first visit to physicians to the time of diagnosis was about 46.69 months (10 days~264mon). There was elevated level of serum ALT and AST, hyperbilirubinemia, hyperglobulimenia, with predominant elevation of ALP, GGT and different kinds of auto-antibodies, for example AMA, AMA-M2.ConclusionPBC affects females clinically and has severe liver impairment.
作者 曾跃萍
机构地区 北京地坛医院
出处 《实用肝脏病杂志》 CAS 2004年第4期205-207,共3页 Journal of Practical Hepatology
  • 相关文献

参考文献7

  • 1[1]James OF, Bhopal R, Hower D, et al. Primary biliary cirrhosis once rare, now common in the United Kingdon? Hepatology,1999, 30: 390 ~ 394
  • 2姚光弼.中国人原发性胆汁性肝硬化的前瞻性研究[J].肝脏,2002,7(3):146-149. 被引量:63
  • 3[3]Heathcote EJ. Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines.Hepatology, 2000, 31: 1005 ~ 1013
  • 4[4]Neuberger J. Primary biliary cirrhsis. Lancet, 1997,350:875 ~879
  • 5[5]Metcalf JV, James OFW. The geoepidemiology of primary biliary cirrhosis. Hepatology, 1996, 22:108
  • 6叶维法 钟振义.肝病免疫学.抗体和免疫球蛋白[M].天津:天津科学技术出版社,1997.19-47.
  • 7孙丽华,张跃新.自身免疫性肝炎的自身抗体及临床意义[J].实用肝脏病杂志,2004,7(2):125-127. 被引量:8

二级参考文献23

  • 1沈麦琪 沈晓黎 等.复合组织切片技术在测定自身抗体中的应用[J].上海免疫学杂志,1984,4:167-167.
  • 2史济招 贾克明 等.毛细胆管胆汁性肝硬化[J].中华内科杂志,1955,3:190-197.
  • 3[1]Berg PA, klein R. Autoimmune hepatitis and overlap syndrome:diagnosis. Schweiz Rundsch Med Prax, 2002,91(34): 1339~46
  • 4[2]McFarlane IG. Definition and classification of autoimmune hepatitis. Semin Liver Dis, 2002,22(4) :317 ~ 24
  • 5[3]Czaja AJ. Treatment strategies in autoimmune hepatitis. Clin Liver Dis, 2002,6(3) :511 ~ 536
  • 6[4]Dalekos GN, Zachou K, Liaskos C, et al. Autoantibodies and defined target autoantigens in autoimmune hepatitis. Eur J Intern,2002,13(5) :293 ~ 303
  • 7[5]Li L, Chen M, Huang DY. et al. Frequency and significance of antibodies to chromatin in autoimmune hepatitis type Ⅰ . J Gastroenterol Hepatol, 2000,16(3):45 ~ 7
  • 8[6]Sobajima J, Ozaki S, Uesugi H, et al. High mobility group (HMG) non-histone chromosomal proteins HMG1 and HMG2 are significant target antigens of perinuclear anti-neutrophil cytoplasmic antibodies in autoimmune hepatitis. Gut, 1999,44(6):867~71
  • 9[7]Albert J, Czaja Deborah K. Diagnosis and treatment of autoimmune hepatitis. Hepatology, 2000,36(2) :479 ~ 97
  • 10[8]Ballot E, Homberg JC, Johanet C. Antibodies to soluble liver antigen: an additional marker in type Ⅰ autoimmune hepatitis. Hepatology, 2000,33(2) :208 ~ 15

共引文献69

同被引文献21

  • 1王鑫,李潇潇.肝硬化护理中优质护理应用效果观察[J].现代养生,2014,0(22):175-175. 被引量:5
  • 2姚定康,谢渭芬,陈伟忠,陈岳祥,杨秀疆,张兴荣,张忠兵,李石.78例原发性胆汁性肝硬化的临床特征[J].解放军医学杂志,2004,29(8):687-689. 被引量:14
  • 3朱赟,王美美.抗线粒体抗体与相关临床疾病[J].临床内科杂志,2007,24(5):355-357. 被引量:2
  • 4James OE W,Bhopal R,Howel D,et al.Primary biliary cirrhosis once rare,now common in the United Kingdom?[J].Hepatology,1999,30(2):390-394.
  • 5Heathcote EJ.Management of primary biliary cirrhosis[J].Hepatology,2000,31(4):1005-1013.
  • 6Inoue K,Hirohara J,Nakano T,et al.Prediction of diagnosis of primary biliary cirrhosis in Japan[J].Liver,1995,15(2):70-77.
  • 7Springer J,Cauch-Dudek K,O'Rourke K,et al.symptomatic primary biliary cirrhosis:a study of its natural history and prognosis[J].Am J Gastroenterol,1999,94:47-53.
  • 8Dvis PA,Leung P,Manns M.M4 and M9 antibodies in the overlap syndrome of primary biliary cirrhosis and chronic active hepatitis:Epitopes or Epiphenomena?[J].Hepatology,1992,16(5):1128-1136.
  • 9ZuKowski TH,Jorgensen RA,Dickson ER,et al.Autoimmune conditions associated with primary biliary cirrhosis:response to ursodeoxy cholic acid therapy[J].Am J Gastroenterol,1998,93(6):958-961.
  • 10Kim WR,Wiesner RH,Therneau TM,et al.Optimal timing of liver transplantation for primary biliary cirrhosis[J].Hepatology,1998,28(1):33-38.

引证文献6

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部